Medicare Enrolled

Dr. Xiuning Le, M.D.

Optician · Boston, MA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
330 BROOKLINE AVE., Boston, MA 02215
6177940793
In practice since 2010 (16 years)
NPI: 1720399074 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Le from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Le? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Le

Dr. Xiuning Le is an optician specialist in Boston, MA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Le performed 389 Medicare services across 219 unique beneficiaries.

Between the years covered by Open Payments, Dr. Le received a total of $267,211 from 33 pharmaceutical and/or device companies across 285 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Le is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ 389 Medicare services $267,211 industry payments

Medicare Practice Summary

Medicare Utilization ↗
389
Medicare services
Bottom 33% in MA for optician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
219
Unique beneficiaries
$95
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~24 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
151 $111 $534
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
111 $74 $265
New patient office visit, complex (60-74 min) 49 $142 $572
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
32 $52 $171
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
31 $76 $267
Advance care planning consultation, first 30 min
A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion.
15 $61 $254
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$267,211
Total received (2018-2024)
Avg $38,173/year across 7 years
Top 3% in MA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
285
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$192,638 (72.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$35,236 (13.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,155 (7.9%)
Scientific / Research
Research funding and grants
$18,182 (6.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$80,961
2023
$67,507
2022
$45,030
2021
$42,471
2020
$10,282
2019
$9,361
2018
$11,600

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$18,135
ABBVIE INC.
$11,462
Daiichi Sankyo Inc.
$9,390
Janssen Biotech, Inc.
$8,690
BioNTech SE
$8,527
EMD Serono, Inc.
$6,210
Regeneron Pharmaceuticals, Inc.
$5,686
Janssen Research & Development, LLC
$3,609
Janssen Scientific Affairs, LLC
$2,452
Bayer Healthcare Pharmaceuticals Inc.
$2,164
Novartis Pharmaceuticals Corporation
$2,025
E.R. Squibb & Sons, L.L.C.
$1,948
Regeneron Healthcare Solutions, Inc.
$282
AstraZeneca UK Limited
$158
Genentech USA, Inc.
$119
JAZZ PHARMACEUTICALS INC.
$104
Top 3 companies account for 48.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$48,552
EMD Serono, Inc.
$35,112
Regeneron Pharmaceuticals, Inc.
$22,115
Merck KGaA
$20,158
Genentech, Inc.
$18,182
Daiichi Sankyo Inc.
$15,121
Blueprint Medicines Corporation
$14,239
AstraZeneca UK Limited
$13,096
ABBVIE INC.
$12,215
Janssen Biotech, Inc.
$10,341
Eli Lilly and Company
$9,000
BioNTech SE
$8,527
Boehringer Ingelheim Pharmaceuticals, Inc.
$6,361
Lilly USA, LLC
$4,406
Bayer Healthcare Pharmaceuticals Inc.
$4,029
Janssen Scientific Affairs, LLC
$3,694
Janssen Research & Development, LLC
$3,609
Janssen Global Services, LLC
$2,938
Taiho Oncology, Inc.
$2,640
Ipsen Biopharmaceuticals, Inc
$2,500
E.R. Squibb & Sons, L.L.C.
$2,173
Novartis Pharmaceuticals Corporation
$2,025
NOVARTIS PHARMACEUTICALS CORPORATION
$1,875
Spectrum Pharmaceuticals Inc.
$1,604
Boehringer Ingelheim International GmbH
$1,040
AbbVie Inc.
$675
Regeneron Healthcare Solutions, Inc.
$398
Genentech USA, Inc.
$257
JAZZ PHARMACEUTICALS INC.
$104
TAIHO ONCOLOGY, INC.
$96
Jazz Pharmaceuticals Inc.
$74
Celgene Corporation
$32
Merck Sharp & Dohme Corporation
$25
Top 3 companies account for 39.6% of all-time payments
Associated products mentioned in payments ›
ALIMTA · Abraxane · Alecensa · Bavencio · CYRAMZA · EMD 1214063 · Enhertu · GILOTRIF · IMFINZI · KEYTRUDA · LIBTAYO · ONIVYDE · RYBREVANT · TABRECTA · TAGRISSO · TEPMETKO · Tepmetko · Tepotinib · Vitrakvi · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (72%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 3% for optician in MA.

Looking for an optician specialist in Boston?
Compare opticians in the Boston area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
830
Per 100K population
106.1
County median income
$92,859
Nearest hospital
BETH ISRAEL DEACONESS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Le is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 3% of MA peers, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Le experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Le performed 151 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Le receive payments from pharmaceutical companies?
Yes. Dr. Le received a total of $267,211 from 33 companies across 285 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Le's costs compare to other opticians in Boston?
Dr. Le's average Medicare payment per service is $95. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Le) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →